Literature DB >> 4282470

Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.

S Müllertz.   

Abstract

Urokinase-activated human plasma was studied by gel electrophoresis, gel filtration, crossed immunoelectrophoresis and electroimmunoassay with specific antibodies and by assay of esterase and protease activity of isolated fractions. Urokinase induced the formation of different components with plasminogen+plasmin antigenicity. At low concentrations of urokinase, a component with a K(D) value of 0.18 by gel filtration and post beta(1) mobility by gel electrophoresis was detected. The isolated component had no enzyme or plasminogen activity. In this plasma sample fibrinogen was not degraded for 10h, but when fibrin was formed, by addition of thrombin, fibrin was quickly lysed, and simultaneously a component with a K(D) value of 0 and alpha(2) mobility appeared, which was probably plasmin in a complex with alpha(2) macroglobulin. This complex showed both esterase and protease activity. After gel filtration with lysine buffer of the clotted and lysed plasma another two components were observed with about the same K(D) value by gel filtration as plasminogen (0.35), but beta(1) and gamma mobilities by gel electrophoresis. They appeared to be modified plasminogen molecules, and possibly plasmin with gamma mobility. Similar processes occurred without fibrin at higher urokinase concentrations. Here a relatively slow degradation of fibrinogen was correlated to the appearance of the plasmin-alpha(2) macroglobulin complex. The fibrin surface appeared to catalyse the ultimate production of active plasmin with a subsequent preferential degradation of fibrin and the formation of a plasmin-alpha(2) macroglobulin complex. The gel filtration and electrophoresis of the plasma protease inhibitors, alpha(1) antitrypsin, inter-alpha-inhibitor, antithrombin III, and C(1)-esterase inhibitor indicated that any complex between plasmin and these inhibitors was completely dissociated. The beta(1) and post beta(1) components appear to lack correlates among components occurring in purified preparations of plasminogen and plasmin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4282470      PMCID: PMC1168382          DOI: 10.1042/bj1430273

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  The action of plasmin on fibrin and fibrinogen in blood.

Authors:  S MULLERTZ
Journal:  Acta Physiol Scand       Date:  1953-03-31

2.  The specific mechanism of activation of human plasminogen to plasmin.

Authors:  L Summaria; B Hsieh; K C Robbins
Journal:  J Biol Chem       Date:  1967-10-10       Impact factor: 5.157

3.  Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma.

Authors:  S Müllertz
Journal:  Scand J Clin Lab Invest       Date:  1972-12       Impact factor: 1.713

4.  Agarose gel electrophoresis.

Authors:  B G Johansson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.

Authors:  P Wallén; B Wiman
Journal:  Biochim Biophys Acta       Date:  1972-01-26

6.  Radioimmunoassay of human plasminogen and plasmin.

Authors:  S F Rabiner; I D Goldfine; A Hart; L Summaria; K C Robbins
Journal:  J Lab Clin Med       Date:  1969-08

7.  Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations.

Authors:  P Wallén; B Wiman
Journal:  Biochim Biophys Acta       Date:  1970-10-20

8.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

9.  Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.

Authors:  P Kok; T Astrup
Journal:  Biochemistry       Date:  1969-01       Impact factor: 3.162

10.  pH and pancreatic enzymes in the human duodenum during digestion of a standard meal.

Authors:  H Worning; S Müllertz
Journal:  Scand J Gastroenterol       Date:  1966       Impact factor: 2.423

View more
  9 in total

1.  Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.

Authors:  U Christensen; I Clemmensen
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

2.  Kinetic properties of the primary inhibitor of plasmin from human plasma.

Authors:  U Christensen; I Clemmensen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

3.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

4.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

Authors:  S Thorsen; S Müllertz; E Suenson; P Kok
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

5.  Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.

Authors:  S Müllertz; S Thorsen; L Sottrup-Jensen
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

Review 6.  Natural inhibitors of fibrinolysis.

Authors:  D Collen
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

7.  Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors.

Authors:  M Sandbjerg Hansen; I Clemmensen
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

8.  The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

Authors:  N Aoki; M Moroi; M Matsuda; K Tachiya
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.